產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-DLK1抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢(xún)訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-DLK1抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-DLK1
Cat. Number:
Anti-DLK1抗體KL-4556R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
This gene encodes a transmembrane protein containing six epidermal growth factor repeats. The protein is involved in the differentiation of several cell types, including adipocytes; it is also thought to be a tumor suppressor. It is one of several imprinted genes located in a region of on chr 14q32. Certain mutations inAnti-DLK1抗體 this imprinted region can cause phenotypes similar to maternal and paternal uniparental disomy of chromosome 14 (UPD14). This gene is expressed from the paternal allele. A polymorphism within this gene has been associated with child and adolescent obesity. The mode of inheritance for this polymorphism is polar overdominance; this non-Mendelian inheritance pattern was first described in sheep with the callipyge phenotype, which is characterized by muscle hypertrophy and decreased fat mass. [provided by RefSeq, Mar 2010].
Also known as:
Adipocyte differentiation inhibitor Anti-DLK1抗體protein; Brevideltin; Delta like 1 homolog; Delta like homolog; Delta like protein; Delta1; DLK 1; DLK; DLK-1; Dlk1; DLK1_HUMAN; FA 1; FA1; Fetal antigen 1; pG2; Preadipocyte factor 1; Pref 1; Pref; Pref1; Pref-1; Protein delta homolog 1; Secredeltin; ZOG; Delta1; PREF1.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Rabbit, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from sheep DLK1.
●
Predicted Molecular Weight: Anti-DLK1抗體42kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be Anti-DLK1抗體determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be Anti-DLK1抗體determined by the end user.
kl928Ra01 腫瘤蛋白p53(TP53)多克隆抗體 Polyclonal Antibody to Tumor Protein p53 (TP53)
kl207Hu01 谷丙轉(zhuǎn)氨酶(ALT)多克隆抗體 Polyclonal Antibody to Alanine Aminotransferase (ALT)
kl207Mu01 谷丙轉(zhuǎn)氨酶(ALT)多克隆抗體 Polyclonal Antibody to Alanine Aminotransferase (ALT)
kl207Ra01 谷丙轉(zhuǎn)氨酶(ALT)多克隆抗體 Polyclonal Antibody to Alanine Aminotransferase (ALT)
kl421Hu01 髓鞘少突膠質(zhì)細(xì)胞糖蛋白(MOG)多克隆抗體 Polyclonal Antibody to Myelin Oligodendrocyte Glycoprotein (MOG)
kl421Mu01 髓鞘少突膠質(zhì)細(xì)胞糖蛋白(MOG)多克隆抗體 Polyclonal Antibody to Myelin Oligodendrocyte Glycoprotein (MOG)
kl421Ra01 髓鞘少突膠質(zhì)細(xì)胞糖蛋白(MOG)多克隆抗體 Polyclonal Antibody to Myelin Oligodendrocyte Glycoprotein (MOG)
kl049Hu01 干擾素γ(IFNγ)多克隆抗體 Polyclonal Antibody to Interferon Gamma (IFNg)
kl049Mu01 干擾素γ(IFNγ)多克隆抗體 Polyclonal Antibody to Interferon Gamma (IFNg)
kl049Ra01 干擾素γ(IFNγ)多克隆抗體 Polyclonal Antibody to Interferon Gamma (IFNg)
kl146Hu01 血管內(nèi)皮生長(zhǎng)因子D(VEGFD)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor D (VEGFD)
kl146Mu01 血管內(nèi)皮生長(zhǎng)因子D(VEGFD)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor D (VEGFD)
kl146Ra01 血管內(nèi)皮生長(zhǎng)因子D(VEGFD)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor D (VEGFD)
kl145Hu01 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor C (VEGFC)
kl145Mu01 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor C (VEGFC)
kl145Ra01 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor C (VEGFC)
